3Weber MA,Julius S,Kjeldsen SE,et al.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE trial[J].Lancet,2004 ; 363 (9426):2049-51.
6Setiawatie, Sukmayadi, Yunaidi DA, et al. comparative bio - availability of two amlodipine formulations in healhy volunteers [ J ]. Arzneimittelforschung, 2007,57 (7) : 467 - 471.
7Arrowsmith JE, Campbell SF, Cross PE, Stubbs JK, Burges RA, Cardiner DG, Blackburn K J, Long - acting dihydropyridine calcium antagonists.1.2 - Akloxymethyl derivatives incorporating basic substituents[J ] . J Med Chem. 1986 Sep; 29(9) .1696 - 702.
8Weber MA,Julius S,Kjeldsen SE,et al.Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial[J].Lancet,2004,363(9426):2049-2051.
9Patil PA,Kothekar MA.Development of safer molecules through chirality[J].J Med Sci,2006,60(10):427-437.
10Umemoto S,Kawahara S,Hashimoto R,et al.Different effects of amlodipine and enalapril on the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-extracellular signal-regulated kinase pathway for induction of vascular smooth muscle cell differentiation in vivo[J].Hyperten Res,2006,29(3):179-186.
7Brassai A, Suvanjeiev RG, Ban EG, et al. Role of synaptic and nonsynaptic glutamate receptors in ischaemia induced neurotoxicitv[J]. Brain Res Bull. 2015.112: 1-6.
8Boger RH, Ron ES. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor[J]. Altem Med Rev, 2005, 10(1): 14-23.
